Total Payments
$11,083
2024 Payments
$121.32
Companies
13
Transactions
19
Medicare Patients
294
Medicare Billing
$48,312
Payment Breakdown by Category
Other$10,000 (90.2%)
Food & Beverage$1,073 (9.7%)
Education$10.28 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $10,000 | 1 | 90.2% |
| Food and Beverage | $1,073 | 17 | 9.7% |
| Education | $10.28 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Integra LifeSciences Corporation | $10,000 | 1 | $0 (2017) |
| Gilead Sciences, Inc. | $438.09 | 4 | $0 (2024) |
| Amarin Pharma Inc. | $155.28 | 2 | $0 (2017) |
| Medtronic USA, Inc. | $137.15 | 2 | $0 (2019) |
| Allergan Inc. | $117.28 | 1 | $0 (2019) |
| AbbVie Inc. | $112.22 | 1 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $25.71 | 2 | $0 (2019) |
| EISAI INC. | $22.88 | 1 | $0 (2019) |
| Veloxis Pharmaceuticals, Inc. | $17.38 | 1 | $0 (2018) |
| Bayer HealthCare Pharmaceuticals Inc. | $15.79 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $121.32 | 1 | Gilead Sciences, Inc. ($121.32) |
| 2023 | $125.00 | 1 | Gilead Sciences, Inc. ($125.00) |
| 2022 | $12.80 | 1 | CONMED Corporation ($12.80) |
| 2020 | $112.22 | 1 | AbbVie Inc. ($112.22) |
| 2019 | $233.71 | 4 | Allergan Inc. ($117.28) |
| 2018 | $181.44 | 6 | Gilead Sciences, Inc. ($107.30) |
| 2017 | $10,297 | 5 | Integra LifeSciences Corporation ($10,000) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/08/2024 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $121.32 | General |
| Category: HBV | ||||||
| 05/17/2023 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: HBV | ||||||
| 08/20/2022 | CONMED Corporation | AIRSEAL (Device) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: GENERAL SURGERY | ||||||
| 01/30/2020 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $112.22 | General |
| Category: VIROLOGY | ||||||
| 12/06/2019 | Allergan Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $117.28 | General |
| Category: CYSTIC FIBROSIS | ||||||
| 03/15/2019 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $13.55 | General |
| 02/20/2019 | EISAI INC. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $22.88 | General |
| Category: Oncology | ||||||
| 02/08/2019 | Medtronic USA, Inc. | INTELLIS (Device) | Food and Beverage | In-kind items and services | $80.00 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/03/2018 | Bayer HealthCare Pharmaceuticals Inc. | Nexavar (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: Oncology | ||||||
| 06/22/2018 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $12.16 | General |
| Category: Oncology | ||||||
| 02/02/2018 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $107.30 | General |
| Category: HBV | ||||||
| 01/31/2018 | Merck Sharp & Dohme Corporation | ZEPATIER (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/11/2018 | Veloxis Pharmaceuticals, Inc. | Envarsus XR (SP) (Drug), Envarsus XR, Envarsus XR | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Immunosuppressant | ||||||
| 01/10/2018 | BAXTER HEALTHCARE | TACHOSIL (Biological) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Surgical Care | ||||||
| 12/08/2017 | Integra LifeSciences Corporation | Duragen (Device), CUSA Clarity, DuraSeal Exact | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $10,000.00 | General |
| Category: Dural Repair | ||||||
| 09/15/2017 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $145.00 | General |
| Category: Hypertriglyceridemia | ||||||
| 09/15/2017 | Amarin Pharma Inc. | Vascepa (Drug) | Education | In-kind items and services | $10.28 | General |
| Category: Hypertriglyceridemia | ||||||
| 05/19/2017 | Medtronic USA, Inc. | ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $57.15 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 02/10/2017 | Gilead Sciences Inc | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $84.47 | General |
| Category: HBV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 145 | 217 | $79,321 | $23,759 |
| 2022 | 4 | 89 | 154 | $58,396 | $16,210 |
| 2021 | 4 | 48 | 54 | $21,736 | $6,037 |
| 2020 | 1 | 12 | 28 | $8,932 | $2,306 |
Total Patients
294
Total Services
453
Medicare Billing
$48,312
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 37 | 52 | $15,704 | $6,843 | 43.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 16 | 64 | $20,416 | $5,986 | 29.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 31 | 36 | $22,356 | $4,908 | 22.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 24 | 24 | $11,016 | $3,814 | 34.6% |
| 76998 | Ultrasonic guidance during surgery | Facility | 2023 | 24 | 24 | $6,072 | $1,151 | 19.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 13 | 17 | $3,757 | $1,057 | 28.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 30 | 36 | $22,356 | $5,558 | 24.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 21 | 67 | $21,373 | $5,349 | 25.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 24 | 36 | $10,872 | $4,569 | 42.0% |
| 76998 | Ultrasonic guidance during surgery | Facility | 2022 | 14 | 15 | $3,795 | $733.57 | 19.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 14 | 20 | $6,380 | $2,121 | 33.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 11 | 11 | $6,831 | $1,723 | 25.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 11 | 11 | $5,489 | $1,603 | 29.2% |
| 76998 | Ultrasonic guidance during surgery | Facility | 2021 | 12 | 12 | $3,036 | $590.16 | 19.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 12 | 28 | $8,932 | $2,306 | 25.8% |
About Dr. Gary Xiao, MD
Dr. Gary Xiao, MD is a Transplant Surgery healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/16/2007. The National Provider Identifier (NPI) number assigned to this provider is 1043354616.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Xiao, MD has received a total of $11,083 in payments from pharmaceutical and medical device companies, with $121.32 received in 2024. These payments were reported across 19 transactions from 13 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($10,000).
As a Medicare-enrolled provider, Xiao has provided services to 294 Medicare beneficiaries, totaling 453 services with total Medicare billing of $48,312. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Transplant Surgery
- Other Specialties Surgery
- Location Philadelphia, PA
- Active Since 02/16/2007
- Last Updated 03/22/2021
- Taxonomy Code 204F00000X
- Entity Type Individual
- NPI Number 1043354616
Products in Payments
- Duragen (Device) $10,000
- Vemlidy (Drug) $438.09
- Vascepa (Drug) $155.28
- ZENPEP (Drug) $117.28
- MAVYRET (Drug) $112.22
- INTELLIS (Device) $80.00
- ADAPTIVESTIM (Device) $57.15
- Lenvima (Drug) $22.88
- Envarsus XR (SP) (Drug) $17.38
- Nexavar (Drug) $15.79
- ZEPATIER (Drug) $14.83
- TACHOSIL (Biological) $13.98
- AIRSEAL (Device) $12.80
- OPDIVO (Biological) $12.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Transplant Surgery Doctors in Philadelphia
Dr. Adam Bodzin, M.d, M.D
Transplant Surgery — Payments: $118,715
Transplant Surgery $118,715
James Markmann, Md, MD
Transplant Surgery — Payments: $95,323
Transplant Surgery $95,323
Kenneth Margulies, Md, MD
Transplant Surgery — Payments: $32,615
Transplant Surgery $32,615
Kenneth Chavin, Md, Phd, MD, PHD
Transplant Surgery — Payments: $14,584
Transplant Surgery $14,584
Dr. Antonio Di Carlo, Md, MD
Transplant Surgery — Payments: $12,920
Transplant Surgery $12,920
Dr. Kwan Nang Lau, M.d, M.D
Transplant Surgery — Payments: $12,442
Transplant Surgery $12,442